Smyth Edmond. G.; O'Connell Nuala.
Complicated urinary tract infection. Current Opinio in Intectious Diseases. 1998, 11: 63-66
Barrasa Villar L; Guerrero. L.;
Aspiroz. C La infecciones urinarias en los pacientes con sonda vesical no permanente.
Diagnóstico, tratamiento, prevención y líneas de investigación. Med. Clin. (Barc)
1996. 106: 548-554.
Bacheller. C.; Bernstein. J. Urinary
trict infections. Med. Clin. North America. 1997, 81 (3): 719-30
Rosenstiel. N.; Adam. D. Quinolone
antibacterials. Drugs. 1994, 47 (6): 873-883
Hooper D. Quinolones. Principles and
Practice of ínfectious Disease. 1985; : 364-76
Sadaba Díaz de Rada. B.; Escolar. M.;
Azanza. JR; García. E. Quinolonas. Medicine 1998; 7 (72): 3344-3353.
Miyahira. J.; Infección urinaria. Rev.
Med. Hered. 1994, 5(2): 97-104.
Hooton. T- Johnson. C.; Winter. C.;
Kuwamura L.; Rogers E.; Roberts P; Stamm. W Single-dose and three-day regimens of
oflovacin versus trimethoprim-sulfametoxazole for acute cystitis in women. Antimicrobal
Agents Chemother. 1991; 35: 1479-1483.
Garlando. E; Rietiker S.; Táuber C.;
Flepp. M.; Meier B., Luthy R. Single-dose Ciprofloxacin at 100 versus 250 mg. for
treatment of uncomplicated urinary tract infections in women. Antimicrob Agents Chemother
1987; 31 (2): 354-356.
Biering-Sorensen. F; Hoiby N.;
Nordenbo. A.; Raynborg. M.; Bruun. B.; Rahm. V Ciprofloxacin as prophylaxis for urinary
tract intections prospective, ramdomized, cross over placebo con trolled study in patients
with spinal cord lesion. J. Urol. 1994; 151: 105-108.
IMS. 1997. Data Andina S.A.
Eliopoulos G. Mechanisms of bacterial
resistance to antimicrobial drugs, Infections diseases. 1992: 282-283.
Kresken M.; Wiedemann B. Development of
resistance to nalidixic acid and the fluoroquinolones after the introduction of
norfloxacin and ofloxacin. Antimicrob agents Chemother. 1988; 32 (8): 1285-1288.
Lopes AA.; Salgado K; Martinelli R.;
Rocha M. Increase in the frequency of norfloxacina and ciprofloxacina resistance of
bacterial isolated from urine culture. Rev.- Assoc.-Med.-Bras. 1998, 44 (3): 196-200.
Ena J.; Amador C.; Martínez C y Ortiz
V; Pisk factors acquisition of urinary tract infections caused by ciprofloxacin. resistant
Eschenchia coli. J. Urol. 1995; 153: 117-120.
Fernández-Fernández. A.;
Lantero-Benedito-M.; Gastanares - Hernando-MJ.; Undabeitia-Santisteban-E.; Fernández-Santos-F;
Castano-Rodríguez, Gil Fabra; Martínez Castellanos; Otero G. Quinolone resistant
Escherichia coli in the health area ofa 650-bed hospital. Actas Urol-Esp. 1994; 18(6):634-638.
Zavala. E.; Osorio. M.; Acosta. P;
Castro. J.; incidencia de uropatógenos y susceptibilidad antibiótica de Consultorio
Externo vs. Hospitalización en el Hospital Central de la Fuerza Aérea del Perú. Libro
de Resúmenes del Congreso de Medicina Interna 1996: 29.
Iwamoto. C.; Shimabukuro. J.; Huby M.;
Godoy. A.; Albújar C; Tomioka. M.; Arrus. J.; Susceptibilidad antibiótica en infecciones
urinarias en la consulta privada en Lima. Libro de Resúmenes del Congreso de Medicina
Interna. 1996: 26.
Bendaño. T; Betallelux. E; Bendano.
A.; Soto. M.; Saavedra. M.; Lau. D.; Calderón. W. Antimicrobial susceptibility in urine
cultures of ambulatory patients. Libro de Resúmenes del Congreso de Medicina Interna
1998: 121.
Cohen. S.; McMurry. L; Hooper D;
Wolfson. J; Levy. S. Cross-resistance to fluoroquiriolones in multiple-antibiotic-resistance
(MAR). Escherichia coli selected by tetracycline or chloramphenicol. Decresed drug
accumulation asociated with membrane changes in addition to Omp F reduction. Antimicrob
Agents Chemother 1989; 33(8): 1318-1325.
Bauer. W.; Kirby. W; Sherris. J.;
Turck. M. Antibiotic susceptibility testing by a standardized single disk method. Am. J.
Clinic Path. 1996; 36 (3): 493-496.
Grimm. H; in vitro study with
ciprofloxacin: interpretative criteria of Agar Diffusion Test According to standards of
the NCCLS and DIN am J Medicine 1987, 82 suuppi 4A): 376-380
Wilson; Gruneberg. Ciprofioxacin: 10
years of clinical experience. 1997. Maxim Medical, Oxford.
Stamm. W; Hooton. T Management of
urinary tract infections in adults. New Eng. Med. 1993; 329 (18): 1328-1334.
Wisinger. D. Urinary tract infection.
Postgraduate Medicine. 1996,100(5): 229-236.
Hooton. T; Stamm. W. Diagnosis and
treatment of uncomplicated urinary tract infection. Infect. Dis. Clin. North Am. 1997; 11
(3): 551-581.
Warren. J. Nosocomial urinary tract
infections. Principles and practice of infectious diseases. 1985:2607-2615.
Gupta. K; Scholes. D.; Starn. W.
Increasing prevalence of antimicrobial resistance among uropathogens causing uncomplicated
cystitis in women. JAMA 1999; 281 (8): 736-7.38.
Heisig. P; Tschorny. R.
Characterization of fluoroquinolone-resistant mutants of Escherichia coli selected in
vitro. Antimicrob Agents Chemother. 1994; 38 (6): 1284-1291.
Brocklehurst. JC.; Criffiths. L.; Fry
J. The prevalence and sintomatology of urinary infection in the aged population. Geront
Clin. 1968; 10. 242-253
Cometta; Calandra. T; Bille. J.;
Glauser M. P. Escherichia Coli resistant to fluoroquinolones in patients with cancer and
neutropenia. New Eng. J. Med. 1994; 28: 1240
Ronald. A.R.; Harding. G.K Complicated
urinary tract infections. Infect. Dis. Clinic North Am. 1997, 11(3): 583-592.
Stratton.C.W. Avoiding fluoroquinolone
resistance. Postgraduate Medicine. 1997.
